GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Owner Earnings per Share (TTM)

Coloplast AS (OCSE:COLO B) Owner Earnings per Share (TTM) : 18.25 (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Coloplast AS's Owner Earnings per Share (TTM) ended in Sep. 2024 was kr18.25. It's Price-to-Owner-Earnings ratio for today is 45.17.


The historical rank and industry rank for Coloplast AS's Owner Earnings per Share (TTM) or its related term are showing as below:

OCSE:COLO B' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 21.6   Med: 46.37   Max: 86.35
Current: 45.17


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Coloplast AS was 86.35. The lowest was 21.60. And the median was 46.37.


OCSE:COLO B's Price-to-Owner-Earnings is ranked worse than
61.07% of 280 companies
in the Medical Devices & Instruments industry
Industry Median: 33.035 vs OCSE:COLO B: 45.17

Coloplast AS's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was kr5.84. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was kr22.46. It's PE Ratio (TTM) ratio for today is 36.71.

Coloplast AS's EPS without NRI for the three months ended in Sep. 2024 was kr5.47. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was kr22.34. It's PE Ratio without NRI ratio for today is 36.90.


Coloplast AS Owner Earnings per Share (TTM) Historical Data

The historical data trend for Coloplast AS's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Owner Earnings per Share (TTM) Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.96 21.75 18.03 17.29 18.25

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.29 20.10 19.83 18.73 18.25

Competitive Comparison of Coloplast AS's Owner Earnings per Share (TTM)

For the Medical Instruments & Supplies subindustry, Coloplast AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Price-to-Owner-Earnings falls into.



Coloplast AS Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Coloplast AS's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 5,052
Depreciation, Depletion and Amortization 1,290
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 1,195
Change In Working Capital -1,032
Shares Outstanding (Diluted Average) 226

1. Start with "Net Income" from income statement. Coloplast AS's Net Income for the trailing twelve months (TTM) ended in Sep. 2024 was kr5,052 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Coloplast AS's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Sep. 2024 was kr1,290 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Coloplast AS's Change In Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 was kr0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = kr1,195 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Coloplast AS's 5-Year Average Maintenance Capital Expenditure = kr1,195 Mil

5. "Change In Working Capital" is from cashflow statement. Coloplast AS's Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 was kr-1,032 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Coloplast AS's Shares Outstanding (Diluted Average) for the months ended in Sep. 2024 was 225.500 Mil.

Coloplast AS's Onwer Earnings Per Share for Sep. 2024 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 5052 +1290+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-1194.7300143226+-1032)/225.500
=18.25

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=824.40/18.25
=45.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Coloplast AS Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Traded in Other Exchanges
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines